Cargando…

Testosterone in advance age: a New Zealand longitudinal cohort study: Life and Living in Advanced Age (Te Puāwaitanga o Ngā Tapuwae Kia Ora Tonu)

OBJECTIVES: Serum testosterone (T) levels in men decline with age. Low T levels are associated with sarcopenia and frailty in men aged >80 years. T levels have not previously been directly associated with disability in older men. We explored associations between T levels, frailty and disability i...

Descripción completa

Detalles Bibliográficos
Autores principales: Connolly, Martin J, Kerse, Ngaire, Wilkinson, Tim, Menzies, Oliver, Rolleston, Anna, Chong, Yih Harng, Broad, Joanna B, Moyes, Simon A, Jatrana, Santosh, Teh, Ruth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695316/
https://www.ncbi.nlm.nih.gov/pubmed/29133315
http://dx.doi.org/10.1136/bmjopen-2017-016572
_version_ 1783280291776823296
author Connolly, Martin J
Kerse, Ngaire
Wilkinson, Tim
Menzies, Oliver
Rolleston, Anna
Chong, Yih Harng
Broad, Joanna B
Moyes, Simon A
Jatrana, Santosh
Teh, Ruth
author_facet Connolly, Martin J
Kerse, Ngaire
Wilkinson, Tim
Menzies, Oliver
Rolleston, Anna
Chong, Yih Harng
Broad, Joanna B
Moyes, Simon A
Jatrana, Santosh
Teh, Ruth
author_sort Connolly, Martin J
collection PubMed
description OBJECTIVES: Serum testosterone (T) levels in men decline with age. Low T levels are associated with sarcopenia and frailty in men aged >80 years. T levels have not previously been directly associated with disability in older men. We explored associations between T levels, frailty and disability in a cohort of octogenarian men. SETTING: Data from all men from Life and Living in Advanced Age Cohort Study in New Zealand, a longitudinal cohort study in community-dwelling older adults. PARTICIPANTS: Community-dwelling (>80 years) adult men excluding those receiving T treatment or with prostatic carcinoma. OUTCOMES MEASURES: Associations between baseline total testosterone (TT) and calculated free testosterone (fT), frailty (Fried scale) and disability (Nottingham Extended Activities of Daily Living scale (NEADL)) (baseline and 24 months) were examined using multivariate regression and Wald’s χ(2) techniques. Subjects with the lowest quartile of baseline TT and fT values were compared with those in the upper three quartiles. RESULTS: Participants: 243 men, mean (SD) age 83.7 (2.0) years. Mean (SD) TT=17.6 (6.8) nmol/L and fT=225.3 (85.4) pmol/L. On multivariate analyses, lower TT levels were associated with frailty: β=0.41, p=0.017, coefficient of determination (R(2))=0.10 and disability (NEADL) (β=−1.27, p=0.017, R(2)=0.11), low haemoglobin (β=−7.38, p=0.0016, R(2)=0.05), high fasting glucose (β=0.38, p=0.038, R(2)=0.04) and high C reactive protein (CRP) (β=3.57, p=0.01, R(2)=0.06). Low fT levels were associated with frailty (β=0.39, p=0.024, R(2)=0.09) but not baseline NEADL (β=−1.29, p=0.09, R(2)=0.09). Low fT was associated with low haemoglobin (β=−7.83, p=0.0008, R(2)=0.05) and high CRP (β=2.86, p=0.04, R(2)=0.05). Relationships between baseline TT and fT, and 24-month outcomes of disability and frailty were not significant. CONCLUSIONS: In men over 80 years, we confirm an association between T levels and baseline frailty scores. The new finding of association between T levels and disability is potentially relevant to debates on T supplementation in older men, though, as associations were not present at 24 months, further work is needed.
format Online
Article
Text
id pubmed-5695316
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-56953162017-11-24 Testosterone in advance age: a New Zealand longitudinal cohort study: Life and Living in Advanced Age (Te Puāwaitanga o Ngā Tapuwae Kia Ora Tonu) Connolly, Martin J Kerse, Ngaire Wilkinson, Tim Menzies, Oliver Rolleston, Anna Chong, Yih Harng Broad, Joanna B Moyes, Simon A Jatrana, Santosh Teh, Ruth BMJ Open Geriatric Medicine OBJECTIVES: Serum testosterone (T) levels in men decline with age. Low T levels are associated with sarcopenia and frailty in men aged >80 years. T levels have not previously been directly associated with disability in older men. We explored associations between T levels, frailty and disability in a cohort of octogenarian men. SETTING: Data from all men from Life and Living in Advanced Age Cohort Study in New Zealand, a longitudinal cohort study in community-dwelling older adults. PARTICIPANTS: Community-dwelling (>80 years) adult men excluding those receiving T treatment or with prostatic carcinoma. OUTCOMES MEASURES: Associations between baseline total testosterone (TT) and calculated free testosterone (fT), frailty (Fried scale) and disability (Nottingham Extended Activities of Daily Living scale (NEADL)) (baseline and 24 months) were examined using multivariate regression and Wald’s χ(2) techniques. Subjects with the lowest quartile of baseline TT and fT values were compared with those in the upper three quartiles. RESULTS: Participants: 243 men, mean (SD) age 83.7 (2.0) years. Mean (SD) TT=17.6 (6.8) nmol/L and fT=225.3 (85.4) pmol/L. On multivariate analyses, lower TT levels were associated with frailty: β=0.41, p=0.017, coefficient of determination (R(2))=0.10 and disability (NEADL) (β=−1.27, p=0.017, R(2)=0.11), low haemoglobin (β=−7.38, p=0.0016, R(2)=0.05), high fasting glucose (β=0.38, p=0.038, R(2)=0.04) and high C reactive protein (CRP) (β=3.57, p=0.01, R(2)=0.06). Low fT levels were associated with frailty (β=0.39, p=0.024, R(2)=0.09) but not baseline NEADL (β=−1.29, p=0.09, R(2)=0.09). Low fT was associated with low haemoglobin (β=−7.83, p=0.0008, R(2)=0.05) and high CRP (β=2.86, p=0.04, R(2)=0.05). Relationships between baseline TT and fT, and 24-month outcomes of disability and frailty were not significant. CONCLUSIONS: In men over 80 years, we confirm an association between T levels and baseline frailty scores. The new finding of association between T levels and disability is potentially relevant to debates on T supplementation in older men, though, as associations were not present at 24 months, further work is needed. BMJ Publishing Group 2017-11-12 /pmc/articles/PMC5695316/ /pubmed/29133315 http://dx.doi.org/10.1136/bmjopen-2017-016572 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Geriatric Medicine
Connolly, Martin J
Kerse, Ngaire
Wilkinson, Tim
Menzies, Oliver
Rolleston, Anna
Chong, Yih Harng
Broad, Joanna B
Moyes, Simon A
Jatrana, Santosh
Teh, Ruth
Testosterone in advance age: a New Zealand longitudinal cohort study: Life and Living in Advanced Age (Te Puāwaitanga o Ngā Tapuwae Kia Ora Tonu)
title Testosterone in advance age: a New Zealand longitudinal cohort study: Life and Living in Advanced Age (Te Puāwaitanga o Ngā Tapuwae Kia Ora Tonu)
title_full Testosterone in advance age: a New Zealand longitudinal cohort study: Life and Living in Advanced Age (Te Puāwaitanga o Ngā Tapuwae Kia Ora Tonu)
title_fullStr Testosterone in advance age: a New Zealand longitudinal cohort study: Life and Living in Advanced Age (Te Puāwaitanga o Ngā Tapuwae Kia Ora Tonu)
title_full_unstemmed Testosterone in advance age: a New Zealand longitudinal cohort study: Life and Living in Advanced Age (Te Puāwaitanga o Ngā Tapuwae Kia Ora Tonu)
title_short Testosterone in advance age: a New Zealand longitudinal cohort study: Life and Living in Advanced Age (Te Puāwaitanga o Ngā Tapuwae Kia Ora Tonu)
title_sort testosterone in advance age: a new zealand longitudinal cohort study: life and living in advanced age (te puāwaitanga o ngā tapuwae kia ora tonu)
topic Geriatric Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695316/
https://www.ncbi.nlm.nih.gov/pubmed/29133315
http://dx.doi.org/10.1136/bmjopen-2017-016572
work_keys_str_mv AT connollymartinj testosteroneinadvanceageanewzealandlongitudinalcohortstudylifeandlivinginadvancedagetepuawaitangaongatapuwaekiaoratonu
AT kersengaire testosteroneinadvanceageanewzealandlongitudinalcohortstudylifeandlivinginadvancedagetepuawaitangaongatapuwaekiaoratonu
AT wilkinsontim testosteroneinadvanceageanewzealandlongitudinalcohortstudylifeandlivinginadvancedagetepuawaitangaongatapuwaekiaoratonu
AT menziesoliver testosteroneinadvanceageanewzealandlongitudinalcohortstudylifeandlivinginadvancedagetepuawaitangaongatapuwaekiaoratonu
AT rollestonanna testosteroneinadvanceageanewzealandlongitudinalcohortstudylifeandlivinginadvancedagetepuawaitangaongatapuwaekiaoratonu
AT chongyihharng testosteroneinadvanceageanewzealandlongitudinalcohortstudylifeandlivinginadvancedagetepuawaitangaongatapuwaekiaoratonu
AT broadjoannab testosteroneinadvanceageanewzealandlongitudinalcohortstudylifeandlivinginadvancedagetepuawaitangaongatapuwaekiaoratonu
AT moyessimona testosteroneinadvanceageanewzealandlongitudinalcohortstudylifeandlivinginadvancedagetepuawaitangaongatapuwaekiaoratonu
AT jatranasantosh testosteroneinadvanceageanewzealandlongitudinalcohortstudylifeandlivinginadvancedagetepuawaitangaongatapuwaekiaoratonu
AT tehruth testosteroneinadvanceageanewzealandlongitudinalcohortstudylifeandlivinginadvancedagetepuawaitangaongatapuwaekiaoratonu